As of Oct 17
| -0.10 / -1.63%|
The 5 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.25, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +85.95% increase from the last price of 6.05.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.